Seres Therapeutics Inc (NASDAQ:MCRB) does about 4.38M shares in volume on a normal day but saw 6212965 shares change hands in Monday trading. The company now has a market cap of 179.70M USD. Its current market price is $1.19, marking an increase of 2.59% compared to the previous close of $1.16. The 52 week high reached by this stock is $6.26 whilst the lowest price level in 52 weeks is $0.54.
Seres Therapeutics Inc (MCRB) has a 20-day trading average at $0.7941 and the current price is -80.99% off the 52-week high compared with 120.37% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.8458 and its 200-day simple moving average is $1.7406. If we look at the stock’s price movements over the week, volatility stands at 14.75%, which decreases to 11.76% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 77.47 to suggest the stock is overbought.
The consensus objective for the share price is $7.22, suggesting that the stock has a potential upside of 83.52% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on June 26, 2023 when Oppenheimer resumed the stock to “Outperform” and issued a price target of $12. Goldman downgraded its price target at $24-$7.
Seres Therapeutics Inc (MCRB) stock is up 30.91% over the week and 56.05% over the past month. Its price is -15.00% year-to-date and -78.17% over the past year.
To reach the target analysts have set, the stock logically needs to grow 83.52 percent from here.
The company has a return on investment of -70.03% and return on equity of -538.57%. The beta has a value of 1.96. Price to sales ratio is 1.42.
